Clearside Biomedical
(NASDAQ) CLSD
Clearside Biomedical Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$3.33M
Net Income (TTM)
$26.00M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CLSD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Clearside Biomedical
Industry
Pharmaceuticals
Sector
Health CareEmployees
32
CEO
George M. Lasezkay, PharmD
Website
www.clearsidebio.comHeadquarters
Alpharetta, GA 30005, US
CLSD Financials
Key Financial Metrics (TTM)
Gross Margin
86%
Operating Margin
-7%
Net Income Margin
-8%
Return on Equity
55%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.51M
Operating Income
$28.88M
EBITDA
$24.35M
Operating Cash Flow
$24.70M
Capital Expenditure
$977.00K
Free Cash Flow
$25.68M
Cash & ST Invst.
$20.02M
Total Debt
$52.47M
Clearside Biomedical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$201.00K
-80.6%
Gross Profit
$201.00K
-80.6%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
32
N/A
Net Income
$5.97M
+22.3%
EBITDA
$3.32M
+35.6%
Quarterly Fundamentals
Net Cash
$6.36M
+124.1%
Accounts Receivable
$266.00K
-66.2%
Inventory
$0.00
N/A
Long Term Debt
$62.00K
-99.9%
Short Term Debt
$384.00K
+2.9%
Return on Assets
-2.23%
N/A
Return on Invested Capital
-2.59%
N/A
Free Cash Flow
$5.48M
+8.1%
Operating Cash Flow
$5.48M
+7.3%